In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs

Tulathromycin is a semi-synthetic macrolide antimicrobial that has an important role in veterinary medicine for respiratory disease. The objective of the study was to develop a pharmacokinetic/pharmacodynamic (PK/PD) model to examine the efficacy and determine an optimal dosage of tulathromycin intr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li-li Guo, Rui-yuan Gao, Li-hua Wang, Shu-jun Lin, Bing-hu Fang, Yong-da Zhao
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	PK/PD tulathromycin in vivo Haemophilus parasuis guinea pig Veterinary medicine SF600-1100
Acceso en línea:	https://doaj.org/article/5cc00d1e75854ae0825911a52ba7edf7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5cc00d1e75854ae0825911a52ba7edf7
record_format	dspace
spelling	oai:doaj.org-article:5cc00d1e75854ae0825911a52ba7edf72021-11-12T04:59:16ZIn vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs2297-176910.3389/fvets.2021.715887https://doaj.org/article/5cc00d1e75854ae0825911a52ba7edf72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.715887/fullhttps://doaj.org/toc/2297-1769Tulathromycin is a semi-synthetic macrolide antimicrobial that has an important role in veterinary medicine for respiratory disease. The objective of the study was to develop a pharmacokinetic/pharmacodynamic (PK/PD) model to examine the efficacy and determine an optimal dosage of tulathromycin intramuscular (IM) treatment against Haemophilus parasuis infection induced after intraperitoneal inoculation in neutropenic guinea pigs. The PKs of tulathromycin in serum and lung tissue after intramuscular administration at doses of 1, 10, and 20 mg/kg in H. parasuis-infected neutropenic guinea pigs were evaluated by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The tulathromycin minimum inhibitory concentration (MIC) against H. parasuis was ~16 times lower in guinea pig serum (0.03 μg/mL) than in cation-adjusted Mueller-Hinton broth (CAMHB) (0.5 μg/mL). The ratio of the 168-h area under the concentration-time curve (AUC) to MIC (AUC168h/MIC) positively correlated with the in vivo antibacterial effectiveness of tulathromycin (R2 = 0.9878 in serum and R2 = 0.9911 in lung tissue). The computed doses to achieve a reduction of 2-log10 CFU/lung from the ratios of AUC72h/MIC were 5.7 mg/kg for serum and 2.5 mg/kg for lung tissue, which lower than the values of 13.2 mg/kg for serum and 8.9 mg/kg for lung tissue with AUC168h/MIC. In addition, using as objective a 2-log10 reduction and an AUC0−72h as the value of the PK/PD index could be more realistic. The results of this study could provide a solid foundation for the application of PK/PD models in research on macrolide antibiotics used to treat respiratory diseases.Li-li GuoLi-li GuoRui-yuan GaoLi-hua WangShu-jun LinBing-hu FangYong-da ZhaoFrontiers Media S.A.articlePK/PDtulathromycinin vivoHaemophilus parasuisguinea pigVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	PK/PD tulathromycin in vivo Haemophilus parasuis guinea pig Veterinary medicine SF600-1100
spellingShingle	PK/PD tulathromycin in vivo Haemophilus parasuis guinea pig Veterinary medicine SF600-1100 Li-li Guo Li-li Guo Rui-yuan Gao Li-hua Wang Shu-jun Lin Bing-hu Fang Yong-da Zhao In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
description	Tulathromycin is a semi-synthetic macrolide antimicrobial that has an important role in veterinary medicine for respiratory disease. The objective of the study was to develop a pharmacokinetic/pharmacodynamic (PK/PD) model to examine the efficacy and determine an optimal dosage of tulathromycin intramuscular (IM) treatment against Haemophilus parasuis infection induced after intraperitoneal inoculation in neutropenic guinea pigs. The PKs of tulathromycin in serum and lung tissue after intramuscular administration at doses of 1, 10, and 20 mg/kg in H. parasuis-infected neutropenic guinea pigs were evaluated by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The tulathromycin minimum inhibitory concentration (MIC) against H. parasuis was ~16 times lower in guinea pig serum (0.03 μg/mL) than in cation-adjusted Mueller-Hinton broth (CAMHB) (0.5 μg/mL). The ratio of the 168-h area under the concentration-time curve (AUC) to MIC (AUC168h/MIC) positively correlated with the in vivo antibacterial effectiveness of tulathromycin (R2 = 0.9878 in serum and R2 = 0.9911 in lung tissue). The computed doses to achieve a reduction of 2-log10 CFU/lung from the ratios of AUC72h/MIC were 5.7 mg/kg for serum and 2.5 mg/kg for lung tissue, which lower than the values of 13.2 mg/kg for serum and 8.9 mg/kg for lung tissue with AUC168h/MIC. In addition, using as objective a 2-log10 reduction and an AUC0−72h as the value of the PK/PD index could be more realistic. The results of this study could provide a solid foundation for the application of PK/PD models in research on macrolide antibiotics used to treat respiratory diseases.
format	article
author	Li-li Guo Li-li Guo Rui-yuan Gao Li-hua Wang Shu-jun Lin Bing-hu Fang Yong-da Zhao
author_facet	Li-li Guo Li-li Guo Rui-yuan Gao Li-hua Wang Shu-jun Lin Bing-hu Fang Yong-da Zhao
author_sort	Li-li Guo
title	In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
title_short	In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
title_full	In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
title_fullStr	In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
title_full_unstemmed	In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
title_sort	in vivo pharmacokinetic/pharmacodynamic (pk/pd) profiles of tulathromycin in an experimental intraperitoneal haemophilus parasuis infection model in neutropenic guinea pigs
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/5cc00d1e75854ae0825911a52ba7edf7
work_keys_str_mv	AT liliguo invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs AT liliguo invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs AT ruiyuangao invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs AT lihuawang invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs AT shujunlin invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs AT binghufang invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs AT yongdazhao invivopharmacokineticpharmacodynamicpkpdprofilesoftulathromycininanexperimentalintraperitonealhaemophilusparasuisinfectionmodelinneutropenicguineapigs
_version_	1718431171103162368

In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs

Ejemplares similares